CELG - Celgene Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income4,046,0002,940,0001,999,0001,602,000
Operating Activities, Cash Flows Provided By or Used In
Depreciation635,000471,000505,000402,000
Adjustments To Net Income725,000-336,000926,000537,000
Changes In Accounts Receivables-178,000-236,000-222,000-305,000
Changes In Liabilities331,000293,000626,000564,000
Changes In Inventories82,000-42,000-55,000-51,000
Changes In Other Operating Activities-77,000-73,00085,000-326,000
Total Cash Flow From Operating Activities5,171,0005,246,0004,165,0002,785,000
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-330,000-279,000-236,000-286,000
Investments2,560,000-2,585,000-765,0001,730,000
Other Cash flows from Investing Activities--27,000-1,000-8,000
Total Cash Flows From Investing Activities-6,418,000-2,891,000-1,002,000-6,259,000
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings4,452,0001,564,0001,564,0007,297,000
Other Cash Flows from Financing Activities-40,000-40,000-33,000-9,000
Total Cash Flows From Financing Activities-1,540,000-1,584,000-1,834,0004,283,000
Effect Of Exchange Rate Changes8,00072,000-39,000-51,000
Change In Cash and Cash Equivalents-2,779,000843,0001,290,000758,000